Remote glucose check
This article was originally published in The Gray Sheet
Executive Summary
Scottsdale, Ariz., health technology firm MedApps gains 510(k) clearance for its d-PAL remote monitoring system for diabetics July 3. The system connects to Johnson & Johnson/LifeScan's One Touch Ultra glucose monitor to allow wireless transfer of daily glucose readings to a central server. Patients can interact with the system via cell phone and remotely answer additional questions to give their doctors other pertinent information. MedApps, founded in July 2006, is developing similar products to monitor blood pressure in congestive heart failure patients, breathing efficiency for respiratory diseases, tremors in Parkinson's disease, and for use with implantable defibrillators and pacemakers...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.